Axogen Operating Income from 2010 to 2026
| AXGN Stock | USD 35.30 0.29 0.83% |
Operating Income | First Reported 1986-09-30 | Previous Quarter 1.7 M | Current Value 1.9 M | Quarterly Volatility 2.9 M |
Check Axogen financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Axogen's main balance sheet or income statement drivers, such as Depreciation And Amortization of 9.5 M, Interest Expense of 9.9 M or Total Revenue of 226.2 M, as well as many indicators such as Price To Sales Ratio of 3.33, Dividend Yield of 0.27 or PTB Ratio of 6.0. Axogen financial statements analysis is a perfect complement when working with Axogen Valuation or Volatility modules.
Axogen | Operating Income | Build AI portfolio with Axogen Stock |
Evaluating Axogen's Operating Income across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Axogen Inc's fundamental strength.
Latest Axogen's Operating Income Growth Pattern
Below is the plot of the Operating Income of Axogen Inc over the last few years. Operating Income is the amount of profit realized from Axogen Inc operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Axogen Inc is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. It is earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations. Axogen's Operating Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Axogen's overall financial position and show how it may be relating to other accounts over time.
| Operating Income | 10 Years Trend |
|
Operating Income |
| Timeline |
Axogen Operating Income Regression Statistics
| Arithmetic Mean | (12,943,296) | |
| Geometric Mean | 8,790,914 | |
| Coefficient Of Variation | (77.91) | |
| Mean Deviation | 8,707,438 | |
| Median | (9,266,710) | |
| Standard Deviation | 10,084,766 | |
| Sample Variance | 101.7T | |
| Range | 31.9M | |
| R-Value | (0.26) | |
| Mean Square Error | 101T | |
| R-Squared | 0.07 | |
| Significance | 0.31 | |
| Slope | (526,147) | |
| Total Sum of Squares | 1627.2T |
Axogen Operating Income History
Other Fundumenentals of Axogen Inc
Axogen Operating Income component correlations
Click cells to compare fundamentals
About Axogen Financial Statements
Axogen investors utilize fundamental indicators, such as Operating Income, to predict how Axogen Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Operating Income | -3 M | -3.1 M | |
| Non Operating Income Net Other | 1.6 M | 1.7 M |
Pair Trading with Axogen
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Axogen position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Axogen will appreciate offsetting losses from the drop in the long position's value.Moving against Axogen Stock
| 0.87 | OTC | Ocumetics Technology Corp | PairCorr |
| 0.81 | ELAB | Elevai Labs Common | PairCorr |
| 0.72 | VVOS | Vivos Therapeutics | PairCorr |
| 0.66 | IPD | Impedimed Earnings Call This Week | PairCorr |
| 0.64 | VNRX | Volitionrx | PairCorr |
The ability to find closely correlated positions to Axogen could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Axogen when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Axogen - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Axogen Inc to buy it.
The correlation of Axogen is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Axogen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Axogen Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Axogen can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Axogen Correlation against competitors. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Will Health Care Equipment & Supplies sector continue expanding? Could Axogen diversify its offerings? Factors like these will boost the valuation of Axogen. If investors know Axogen will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Axogen data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (0.05) | Revenue Per Share | Quarterly Revenue Growth 0.235 | Return On Assets | Return On Equity |
Investors evaluate Axogen Inc using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Axogen's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Axogen's market price to deviate significantly from intrinsic value.
Understanding that Axogen's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Axogen represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Conversely, Axogen's market price signifies the transaction level at which participants voluntarily complete trades.